{"id":14068,"date":"2024-03-27T14:14:38","date_gmt":"2024-03-27T14:14:38","guid":{"rendered":"https:\/\/www.gutblick.ch\/de\/?post_type=useful-information&#038;p=14068"},"modified":"2024-05-15T12:45:29","modified_gmt":"2024-05-15T12:45:29","slug":"gutblick-research-studie-spectrum","status":"publish","type":"useful-information","link":"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/","title":{"rendered":"Gutblick Research startet die Studie \u00abSpectrum\u00bb"},"content":{"rendered":"<div itemscope itemtype=\"http:\/\/schema.org\/Article\" class=\"header-small-block container1200 mb120 mt120\"><div class=\"container\" > <div class=\"content\" > <div class=\"header-small-block-wrap\" > <div class=\"header-small-block__content\" > <h1 itemprop=\"name\" class=\"header-small-block__name semiBold h3\" > <span class=\"header-small-block__title h3\" > Gutblick Research startet <\/span><br>die Studie \u00abSpectrum\u00bb  <\/h1 > <p class=\"header-small-block__subtitle mt16\" > <\/p > <\/div > <div class=\"header-small-block__image\" > <img loading=\"lazy\" decoding=\"async\" width=\"730\" height=\"410\" src=\"https:\/\/www.gutblick.ch\/app\/uploads\/2024\/03\/gutblick-forscht_730x410px-2.png\" class=\"img__small__header\" alt=\"\" srcset=\"https:\/\/www.gutblick.ch\/app\/uploads\/2024\/03\/gutblick-forscht_730x410px-2.png 730w, https:\/\/www.gutblick.ch\/app\/uploads\/2024\/03\/gutblick-forscht_730x410px-2-300x168.png 300w\" sizes=\"auto, (max-width: 730px) 100vw, 730px\" \/><\/div > <\/div > <\/div > <\/div > <\/div > \n\n<div class=\"title-content-block container1364 mb120 mt48\"><div class=\"container\"><div class=\"content\"><div class=\"mt24 mb24 max830 preloaded__content fade\"><p><strong>Am 18. M\u00e4rz 2024 war es so weit: Die erste industriegesponserte Studie \u00abSpectrum\u00bb bei Gutblick hat unter der Leitung von Prof. Dr. Dr. Marion Munk begonnen. Untersucht wird die Wirksamkeit von Aflibercept 8 mg bei Patient:innen mit diabetischem Makula\u00f6dem oder neovaskul\u00e4rer altersbedingter Makuladegeneration.<\/strong><\/p>\n<\/div><div class=\"mt24 mb24 max830 preloaded__content fade\"><p>Aflibercept (Eylea) 2 mg ist eine seit 10 Jahren etablierte Behandlungsoption bei diabetischem Makula\u00f6dem (DME) und neovaskul\u00e4rer AMD (nAMD) mit \u00fcberzeugendem Wirksamkeits- und Sicherheitsprofil. Um die Behandlungslast zu reduzieren und Injektionsintervalle zu verl\u00e4ngern, wurde die Wirksamkeit von Eylea in h\u00f6heren Dosierungen untersucht: Anfang Januar 2024 wurde Eylea 8 mg in der Schweiz zugelassen, basierend auf positiven Ergebnissen von zwei randomisierten, doppelt verblindeten, aktiv-kontrollierten Zulassungsstudien (PULSAR f\u00fcr nAMD und PHOTON f\u00fcr das DME). Patient:innen mit nAMD oder DME haben nun die M\u00f6glichkeit, von Eylea 8 mg mit weniger h\u00e4ufigen Injektionen (verl\u00e4ngertes Behandlungsintervall bis zu 4 Monate) bei vergleichbarer Wirksamkeit und Sicherheit wie Eylea 2 mg zu profitieren.<\/p>\n<\/div><div class=\"mt24 mb24 max830 preloaded__content fade\"><p>Erfahren Sie mehr zum Thema in zwei <strong><a href=\"https:\/\/europe.ophthalmologytimes.com\/view\/efficacy-and-safety-of-aflibercept-8-mg-in-pulsar-trial-in-neovascular-amd\">Fachvortr\u00e4gen von Marion Munk<\/a><\/strong>, die von der <strong>Ophthalmology Times<\/strong> ver\u00f6ffentlicht wurden (06.05.2024).<\/p>\n<\/div><div class=\"mt24 mb24 max830 preloaded__content fade\"><p>Etwa 2500 Patient:innen aus 15 L\u00e4nder in den Regionen Nordamerika, Europa, Naher Osten und Asien-Pazifik werden an der Studie teilnehmen.<\/p>\n<\/div><div class=\"mt24 mb24 max830 preloaded__content fade\"><p>Forschung ist teuer. Gerade bei Medikamentenentwicklung oder Entwicklung neuer Behandlungsmethoden ist es \u00fcblich, dass die Industrie die Forschung finanziert.<\/p>\n<\/div><\/div><\/div><\/div>","protected":false},"featured_media":14098,"menu_order":0,"template":"","category_useful_information":[65],"class_list":["post-14068","useful-information","type-useful-information","status-publish","has-post-thumbnail","hentry","category_useful_information-allgemeine-informationen"],"acf":{"sidebar_excerpt":"Die erste industriegesponserte Studie \u00abSpectrum\u00bb bei Gutblick unter der Leitung von Prof. Dr. Dr. Marion Munk ist gestartet. Untersucht wird die Wirksamkeit von Aflibercept 8 mg bei Patient:innen mit diabetischem Makula\u00f6dem oder neovaskul\u00e4rer altersbedingter Makuladegeneration."},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Gutblick Research startet die Studie \u00abSpectrum\u00bb - Gutblick<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gutblick Research startet die Studie \u00abSpectrum\u00bb - Gutblick\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/\" \/>\n<meta property=\"og:site_name\" content=\"Gutblick\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-15T12:45:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.gutblick.ch\/app\/uploads\/2024\/03\/Reserve_Forschung_Studie_V01.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/\",\"url\":\"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/\",\"name\":\"Gutblick Research startet die Studie \u00abSpectrum\u00bb - Gutblick\",\"isPartOf\":{\"@id\":\"https:\/\/www.gutblick.ch\/de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.gutblick.ch\/app\/uploads\/2024\/03\/Reserve_Forschung_Studie_V01.png\",\"datePublished\":\"2024-03-27T14:14:38+00:00\",\"dateModified\":\"2024-05-15T12:45:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/#primaryimage\",\"url\":\"https:\/\/www.gutblick.ch\/app\/uploads\/2024\/03\/Reserve_Forschung_Studie_V01.png\",\"contentUrl\":\"https:\/\/www.gutblick.ch\/app\/uploads\/2024\/03\/Reserve_Forschung_Studie_V01.png\",\"width\":1080,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.gutblick.ch\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gutblick Research startet die Studie \u00abSpectrum\u00bb\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.gutblick.ch\/de\/#website\",\"url\":\"https:\/\/www.gutblick.ch\/de\/\",\"name\":\"Gutblick\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.gutblick.ch\/de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.gutblick.ch\/de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.gutblick.ch\/de\/#organization\",\"name\":\"Gutblick\",\"url\":\"https:\/\/www.gutblick.ch\/de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/www.gutblick.ch\/de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.gutblick.ch\/app\/uploads\/2022\/09\/Gutblick-pos_RGB-1-1.svg\",\"contentUrl\":\"https:\/\/www.gutblick.ch\/app\/uploads\/2022\/09\/Gutblick-pos_RGB-1-1.svg\",\"caption\":\"Gutblick\"},\"image\":{\"@id\":\"https:\/\/www.gutblick.ch\/de\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gutblick Research startet die Studie \u00abSpectrum\u00bb - Gutblick","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/","og_locale":"de_DE","og_type":"article","og_title":"Gutblick Research startet die Studie \u00abSpectrum\u00bb - Gutblick","og_url":"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/","og_site_name":"Gutblick","article_modified_time":"2024-05-15T12:45:29+00:00","og_image":[{"width":1080,"height":1080,"url":"https:\/\/www.gutblick.ch\/app\/uploads\/2024\/03\/Reserve_Forschung_Studie_V01.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/","url":"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/","name":"Gutblick Research startet die Studie \u00abSpectrum\u00bb - Gutblick","isPartOf":{"@id":"https:\/\/www.gutblick.ch\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/#primaryimage"},"image":{"@id":"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gutblick.ch\/app\/uploads\/2024\/03\/Reserve_Forschung_Studie_V01.png","datePublished":"2024-03-27T14:14:38+00:00","dateModified":"2024-05-15T12:45:29+00:00","breadcrumb":{"@id":"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/"]}]},{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/#primaryimage","url":"https:\/\/www.gutblick.ch\/app\/uploads\/2024\/03\/Reserve_Forschung_Studie_V01.png","contentUrl":"https:\/\/www.gutblick.ch\/app\/uploads\/2024\/03\/Reserve_Forschung_Studie_V01.png","width":1080,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.gutblick.ch\/de\/gutblick-research-studie-spectrum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gutblick.ch\/de\/"},{"@type":"ListItem","position":2,"name":"Gutblick Research startet die Studie \u00abSpectrum\u00bb"}]},{"@type":"WebSite","@id":"https:\/\/www.gutblick.ch\/de\/#website","url":"https:\/\/www.gutblick.ch\/de\/","name":"Gutblick","description":"","publisher":{"@id":"https:\/\/www.gutblick.ch\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gutblick.ch\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/www.gutblick.ch\/de\/#organization","name":"Gutblick","url":"https:\/\/www.gutblick.ch\/de\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.gutblick.ch\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.gutblick.ch\/app\/uploads\/2022\/09\/Gutblick-pos_RGB-1-1.svg","contentUrl":"https:\/\/www.gutblick.ch\/app\/uploads\/2022\/09\/Gutblick-pos_RGB-1-1.svg","caption":"Gutblick"},"image":{"@id":"https:\/\/www.gutblick.ch\/de\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.gutblick.ch\/de\/wp-json\/wp\/v2\/useful-information\/14068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gutblick.ch\/de\/wp-json\/wp\/v2\/useful-information"}],"about":[{"href":"https:\/\/www.gutblick.ch\/de\/wp-json\/wp\/v2\/types\/useful-information"}],"version-history":[{"count":22,"href":"https:\/\/www.gutblick.ch\/de\/wp-json\/wp\/v2\/useful-information\/14068\/revisions"}],"predecessor-version":[{"id":14373,"href":"https:\/\/www.gutblick.ch\/de\/wp-json\/wp\/v2\/useful-information\/14068\/revisions\/14373"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gutblick.ch\/de\/wp-json\/wp\/v2\/media\/14098"}],"wp:attachment":[{"href":"https:\/\/www.gutblick.ch\/de\/wp-json\/wp\/v2\/media?parent=14068"}],"wp:term":[{"taxonomy":"category_useful_information","embeddable":true,"href":"https:\/\/www.gutblick.ch\/de\/wp-json\/wp\/v2\/category_useful_information?post=14068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}